Redmile-Group

AI_NATIVE detailed information: This accession holds the following tickers:[
  "AKRO",
  "KRYS",
  "ABSI",
  "MASI",
  "CBLL",
  "ALXO",
  "FOLD",
  "BSX",
  "PRME",
  "RGNX",
  "LIVN",
  "ANNX",
  "ATXS",
  "SLN",
  "IGMS",
  "NUVB",
  "NRIX",
  "STOK",
  "KYMR",
  "REPL",
  "ADCT",
  "KROS",
  "NGNE",
  "ALLK",
  "ATRA",
  "ESTA",
  "SRRK",
  "FATE",
  "IVVD",
  "LVTX",
  "RPTX",
  "STTK",
  "PODD",
  "IDYA",
  "ZYME",
  "RAPT",
  "SLDB",
  "FDMT",
  "PLRX",
  "COGT",
  "ETNB",
  "BOLD",
  "PEN",
  "IMNM",
  "KLRS",
  "VTYX",
  "VERV",
  "XERS",
  "ORKA",
  "BHVN",
  "IMVT",
  "IRTC",
  "BEAM",
  "BNTX",
  "CLDX",
  "CYTK"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 56
Total Value: 1057997904
Accession Number: 0001104659-25-049578
Form Type: 13F-HR
CIK: redmile-group
Manager Name: Redmile-Group

Data Enrichment

100% identified

56 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

56 positions • $1.1B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 3

Sort by:

ESTABLISHMENT LABS HOLDINGS INC.

ESTA|G31249108

Shares:335.4K

Value:$13.7M

% of Portfolio:1.3% ($13.7M/$1.1B)

Annexon, Inc.

ANNX|03589W102

Shares:6.3M

Value:$12.2M

% of Portfolio:1.1% ($12.2M/$1.1B)

Celldex Therapeutics, Inc.

CLDX|15117B202

Shares:590.2K

Value:$10.7M

% of Portfolio:1.0% ($10.7M/$1.1B)

FATE THERAPEUTICS INC

FATE|31189P102

Shares:12.9M

Value:$10.2M

% of Portfolio:1.0% ($10.2M/$1.1B)

IDEAYA Biosciences, Inc.

IDYA|45166A102

Shares:534.6K

Value:$8.8M

% of Portfolio:0.8% ($8.8M/$1.1B)

Immunovant, Inc.

IMVT|45258J102

Shares:490.4K

Value:$8.4M

% of Portfolio:0.8% ($8.4M/$1.1B)

Ceribell, Inc.

CBLL|15678C102

Shares:435.2K

Value:$8.4M

% of Portfolio:0.8% ($8.4M/$1.1B)

RAPT Therapeutics, Inc.

RAPT|75382E109

Shares:6.5M

Value:$7.9M

% of Portfolio:0.7% ($7.9M/$1.1B)

Solid Biosciences Inc.

SLDB|83422E204

Shares:2.0M

Value:$7.5M

% of Portfolio:0.7% ($7.5M/$1.1B)

INSULET CORP

PODD|45784P101

Shares:27.1K

Value:$7.1M

% of Portfolio:0.7% ($7.1M/$1.1B)

BioNTech SE

BNTX|09075V102

Shares:73.1K

Value:$6.7M

% of Portfolio:0.6% ($6.7M/$1.1B)

Silence Therapeutics plc

SLN|82686Q101

Shares:2.2M

Value:$6.2M

% of Portfolio:0.6% ($6.2M/$1.1B)

Penumbra Inc

PEN|70975L107

Shares:22.8K

Value:$6.1M

% of Portfolio:0.6% ($6.1M/$1.1B)

iRhythm Technologies, Inc.

IRTC|450056106

Shares:56.8K

Value:$6.0M

% of Portfolio:0.6% ($6.0M/$1.1B)

Keros Therapeutics, Inc.

KROS|492327101

Shares:552.5K

Value:$5.6M

% of Portfolio:0.5% ($5.6M/$1.1B)

Verve Therapeutics, Inc.

VERV|92539P101

Shares:1.2M

Value:$5.5M

% of Portfolio:0.5% ($5.5M/$1.1B)

Nuvation Bio Inc.

NUVB|67080N101

Shares:3.0M

Value:$5.3M

% of Portfolio:0.5% ($5.3M/$1.1B)

Shattuck Labs, Inc.

STTK|82024L103

Shares:5.5M

Value:$5.3M

% of Portfolio:0.5% ($5.3M/$1.1B)

MASIMO CORP

MASI|574795100

Shares:26.1K

Value:$4.3M

% of Portfolio:0.4% ($4.3M/$1.1B)

Prime Medicine, Inc.

PRME|74168J101

Shares:2.1M

Value:$4.1M

% of Portfolio:0.4% ($4.1M/$1.1B)

Instrument	Shares		Other Manager	Value	% of Portfolio
ESTABLISHMENT LABS HOLDINGS INC.(ESTAcusipG31249108)	335.4K	QoQ +4.75% (-15.2K) YoY +193.30% (+221.0K)	All Managers (Combined)	$13.7M	1.3% ($13.7M/$1.1B)	QoQ -7.21% (-$1.1M) YoY +135.13% (+$7.9M)
Annexon, Inc.(ANNXcusip03589W102)	6.3M	QoQ 0.00% (-0) YoY +14.49% (-797.5K)	All Managers (Combined)	$12.2M	1.1% ($12.2M/$1.1B)	QoQ -62.37% (-$20.2M) YoY -69.18% (-$27.3M)
Celldex Therapeutics, Inc.(CLDXcusip15117B202)	590.2K	QoQ -4.15% (-25.6K) YoY -34.16% (-306.3K)	All Managers (Combined)	$10.7M	1.0% ($10.7M/$1.1B)	QoQ -31.16% (-$4.8M) YoY -71.52% (-$26.9M)
FATE THERAPEUTICS INC(FATEcusip31189P102)	12.9M	QoQ 0.00% (-0) YoY -2.24% (-296.1K)	All Managers (Combined)	$10.2M	1.0% ($10.2M/$1.1B)	QoQ -52.11% (-$11.1M) YoY -89.47% (-$86.5M)
IDEAYA Biosciences, Inc.(IDYAcusip45166A102)	534.6K	QoQ -13.67% (-84.7K) YoY -42.05% (-388.1K)	All Managers (Combined)	$8.8M	0.8% ($8.8M/$1.1B)	QoQ -44.98% (-$7.2M) YoY -78.37% (-$31.7M)
Immunovant, Inc.(IMVTcusip45258J102)	490.4K	QoQ -14.24% (-81.4K) YoY -49.42% (-479.2K)	All Managers (Combined)	$8.4M	0.8% ($8.4M/$1.1B)	QoQ -40.83% (-$5.8M) YoY -73.24% (-$22.9M)
Ceribell, Inc.(CBLLcusip15678C102)	435.2K	QoQ 0.00% (-0) YoY NEW(+435.2K)	All Managers (Combined)	$8.4M	0.8% ($8.4M/$1.1B)	QoQ -25.77% (-$2.9M) YoY NEW(+$8.4M)
RAPT Therapeutics, Inc.(RAPTcusip75382E109)	6.5M	QoQ 0.00% (-0) YoY +877.55% (+5.8M)	All Managers (Combined)	$7.9M	0.7% ($7.9M/$1.1B)	QoQ -22.78% (-$2.3M) YoY +32.80% (+$2.0M)
Solid Biosciences Inc.(SLDBcusip83422E204)	2.0M	QoQ +228.18% (+1.4M) YoY NEW(+2.0M)	All Managers (Combined)	$7.5M	0.7% ($7.5M/$1.1B)	QoQ +203.57% (+$5.0M) YoY NEW(+$7.5M)
INSULET CORP(PODDcusip45784P101)	27.1K	QoQ +183.59% (+17.6K) YoY NEW(+27.1K)	All Managers (Combined)	$7.1M	0.7% ($7.1M/$1.1B)	QoQ +185.26% (+$4.6M) YoY NEW(+$7.1M)
BioNTech SE(BNTXcusip09075V102)	73.1K	QoQ -12.45% (-10.4K) YoY NEW(+73.1K)	All Managers (Combined)	$6.7M	0.6% ($6.7M/$1.1B)	QoQ -30.04% (-$2.9M) YoY NEW(+$6.7M)
Silence Therapeutics plc(SLNcusip82686Q101)	2.2M	QoQ -7.68% (-184.4K) YoY +9.23% (-187.3K)	All Managers (Combined)	$6.2M	0.6% ($6.2M/$1.1B)	QoQ -62.16% (-$10.3M) YoY -85.73% (-$37.6M)
Penumbra Inc(PENcusip70975L107)	22.8K	QoQ -11.26% (-2.9K) YoY -48.79% (-21.8K)	All Managers (Combined)	$6.1M	0.6% ($6.1M/$1.1B)	QoQ -0.08% (-$5.0K) YoY -38.65% (-$3.8M)
iRhythm Technologies, Inc.(IRTCcusip450056106)	56.8K	QoQ NEW(+56.8K) YoY NEW(+56.8K)	All Managers (Combined)	$6.0M	0.6% ($6.0M/$1.1B)	QoQ NEW(+$6.0M) YoY NEW(+$6.0M)
Keros Therapeutics, Inc.(KROScusip492327101)	552.5K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$5.6M	0.5% ($5.6M/$1.1B)	QoQ -35.62% (-$3.1M) YoY -84.60% (-$30.9M)
Verve Therapeutics, Inc.(VERVcusip92539P101)	1.2M	QoQ -8.42% (-111.0K) YoY -24.76% (-397.4K)	All Managers (Combined)	$5.5M	0.5% ($5.5M/$1.1B)	QoQ -25.79% (-$1.9M) YoY -74.10% (-$15.8M)
Nuvation Bio Inc.(NUVBcusip67080N101)	3.0M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$5.3M	0.5% ($5.3M/$1.1B)	QoQ -33.83% (-$2.7M) YoY -51.64% (-$5.7M)
Shattuck Labs, Inc.(STTKcusip82024L103)	5.5M	QoQ 0.00% (-0) YoY -1.34% (-75.8K)	All Managers (Combined)	$5.3M	0.5% ($5.3M/$1.1B)	QoQ -21.47% (-$1.4M) YoY -89.51% (-$44.9M)
MASIMO CORP(MASIcusip574795100)	26.1K	QoQ NEW(+26.1K) YoY NEW(+26.1K)	All Managers (Combined)	$4.3M	0.4% ($4.3M/$1.1B)	QoQ NEW(+$4.3M) YoY NEW(+$4.3M)
Prime Medicine, Inc.(PRMEcusip74168J101)	2.1M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$4.1M	0.4% ($4.1M/$1.1B)	QoQ -31.84% (-$1.9M) YoY -71.57% (-$10.4M)